Answers are grounded in this paper and cite their sources.
Lipid lowering following acute coronary syndromes. Current recommendations from the ESC/AHA/ACC2,3 propose high-intensity statins initially, followed by up-titration with ezetimibe or PCSK9 inhibitors if the LDL-C threshold remains >1.8 mmol/L. The Association for Acute CardioVascular Care (ACVC)16 proposes a ‘strike early, strike strong’ approach. In the present study, Schwartz et al.15 provide compelling data that a ‘pulse–chase’ strategy of intensive LDL-C lowering with high-intensity statins and PCSK9 inhibitors, followed by a maintenance of LDL-C according to current guidelines, improves outcomes (inset).
No takes yet. Share an insight, caveat, or question.
Jacques Genest (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: